Tag: bioequivalence generics

Cancer Medication Combinations: Why Bioequivalence for Generics Is So Hard

Generic cancer drug combinations save money but pose unique bioequivalence risks. Small differences in absorption or interactions between drugs can affect safety and effectiveness-especially with narrow therapeutic index agents.

Read More